Selected PUBLICATIONS
Korthuis PT, Hoffmann K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS. (2024). Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241257839.
Luoma J, Allen LR, Gold V, Stauffer CS. (2024). Getting in touch with touch: The importance of studying touch in MDMA-assisted therapy and the development of a new self-report measure. Psychedelic Medicine. 2(1). https://doi.org/10.1089/psymed.2023.0033.
Marseille E, Stauffer CS, Agrawal M, Thambi P, Roddy K, Mithoefer M, Bertozzi SM, Kahn JG. (2023). Group psychedelic therapy: empirical estimates of cost-savings and improved access. Frontiers in Psychiatry. Volume 14. https://doi.org/10.3389/fpsyt.2023.1293243.
Skiles Z, Dixon JR, Friedrich D, Reed D, Stauffer CS. Peer support and psychedelics. Journal of Veterans, Military, and Family Health. 2023. 9(5):80-87. doi:10.3138/jmvfh-2023-0008.
Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS. (2023) Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1123424.
Stauffer CS & Anderson BT. (2023) “Psychedelic-Assisted Group Therapy”. In Butler JA, Herzberg G, Miller RL (Eds.), Integral Psychedelic Therapy: The Non-Ordinary Art of Psychospiritual Healing. Routledge.
Rosati A & Stauffer CS. (2022) “Unicorns and Stardust: A Case Report of Queering MDMA-Assisted Psychotherapy”. In Belser A, Cavnar C, Labate BC (Eds.), Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine (pp. 75-80). Synergetic Press.
Stauffer CS, Brown MR, Adams D, Cassity M, Sevelius J. (2022) MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.932605.
Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022) Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology. https://doi.org/10.1007/s00213-022-06083-y.
Stauffer CS, Morrison TE, Meinzer NK, Leung D, Buffington J, Sheh EG, Neylan TC, et al. (2022) Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial. Psychiatry Research. 308:114340. https://doi.org/10.1016/j.psychres.2021.114340.
Abbas A, Carter A, Jeanne T, Knox R, Korthuis TP, Hamade A, Stauffer CS, Uehling J. (2021) Oregon Psilocybin Advisory Board Rapid Evidence Review and Recommendations. Oregon Health Authority.
Stauffer CS, Samson S, Hickok A, Hoffman WF, Batki SL. (2021) Intranasal oxytocin for stimulant use disorder among male Veterans enrolled in an opioid treatment program: A randomized controlled trial. Frontiers in Psychiatry. 12:804997. doi: 10.3389/fpsyt.2021.804997.
Thorson KR, McKernan SM, West TV, Woolley JD, Mendes WB, Stauffer CS. (2021). Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial. Scientific Reports. 11:21004. https://doi.org/10.1038/s41598-021-99957-8.
Stauffer CS, Anderson BT, Ortigo KM, Woolley J. (2020). Psilocybin-assisted group therapy and attachment: Observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience. ACS Pharmacology & Translational Science. http://dx.doi.org/10.1021/acsptsci.0c00169.
Anderson BT, Danforth A, Daroff R, Stauffer CS, Ekman E, Agin-Liebes G, Trope A, et al. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine. 100538.
Stauffer CS, Moschetto JM, McKernan S, Meinzer NK, Chiang C, Rapier R, Hsiang E, et al. (2020). Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial. Journal of Substance Abuse Treatment. 108059.
Stauffer CS, Meinzer NK, Morrison T, Wen J-H, Radanovich L, Leung D, Niles A, et al. (2019). Effects of oxytocin administration on cue-induced craving in co-occurring alcohol use disorder and PTSD: a within-participant randomized clinical trial. Alcoholism: Clinical and Experimental Research. 43(12):2627-2636. PMID: 31610033.
Rapier R, McKernan SM, Stauffer CS. (2019). The inverse relationship between perceived social support and substance use frequency in socially stigmatized populations. Addictive Behaviors. 10:100188. PMID: 31294075
Trope A, Anderson BT, Hooker AR, Glick G, Stauffer CS, Woolley JD. (2019). Psychedelic-assisted group therapy: A systematic review. Journal of Psychoactive Drugs. 51(2):174-188. PMID: 30950777.
Stauffer CS, Dobberteen L, Woolley JD. (2017). American Alcohol Photo Stimuli (AAPS): A standardized set of alcohol and matched non-alcohol images. The American Journal of Drug and Alcohol Abuse. 43(6):647-655. PMID: 27893279.
Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD. (2016). A two-week pilot study of intranasal oxytocin for cocaine dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction Research and Theory. 24(6):480-498. PMID: 28503120.
Stauffer CS & Woolley JD. (2014). Can we bottle psychosocial treatments for addiction? The role of oxytocin. J Clin Psychiatry. 75(9):1028-9. PMID: 25295428.
A complete list of of publications and other research is available at the links below:
Affiliations
If you'd like to make a donation to the SNAP Lab, you can click on the "MAKE A GIFT' button here, enter your information, select 'OTHER AREA' under the Area of Giving drop-down menu, and manually enter
"Dr. Christopher Stauffer".